(Q61975946)
Statements
An Open, Single Center Trial to Evaluate the Efficacy and Safety of Dose Escalation of Icotinib in Advanced NSCLC Patients After TKI Therapy (English)
0 references
February 2014
0 references
December 2018
0 references
30
0 references
18 year
0 references
75 year
0 references